A talk on advancing the prevention agenda for women and girls occurred on November 20, 2015 in Washington, DC.
Avac Event
PEPFAR’s DREAMS Initiative: Advancing a Prevention Agenda for Women and Girls
Avac Event
Atlanta Counter Conference at the National HIV Prevention Conference
Mirroring the need for intersectionality and inclusivity in the fight to end HIV/AIDS, the People’s Mobilization on the National HIV/AIDS Strategy Counter Conference is a community-built space that aims to empower constituencies most impacted by HIV to be in control of the dialogue. The Counter Conference happened in parallel with the National HIV Prevention Conference (NHPC) as an alternative and accessible space for those who cannot attend the larger NHPC.
Over two days from Monday, December 7 through Tuesday, December 8, activists and advocates hosted conversations at the Center for Civil and Human Rights in Atlanta on the remaining shortcomings of NHAS and its recently released Federal Action Plan, as well as other crucial intersectional issues that were missing from NHPC discussions. Sessions centered on not only raising issues and communities absent from NHAS, but was a vital space to plan collective advocacy work, prioritize policy issues and build power among communities ahead of changing federal leadership in 2016.
Avac Event
CROI 2016
The annual Conference on Retroviruses and Opportunistic Infections (CROI) took place from February 22 to 25 in Boston. Read on for news and materials from the conference and information on our post-CROI webinar series.
News from the Conference
From our blog:
- Reflection on bNAbs and Broadening the Toolbox – Josh Agee
- The Railroad: From science to delivery, freeing young black gay men from a tragic trajectory – Brandon Harrison
- AVAC’s Take On Ring Trial Results—Breaking News in HIV Prevention
- Conducting Research With a Heart: The stories of CROI 2016 Award Recipients – Morenike Ukpong
- Finally, You Can Put a Ring On It! – Anna Miti
- Making Space for Community Educators and Activists at CROI – Ntando Yola
- Push – Julie Patterson
- CROI for the Community – Rob Newells
- Context Matters: Key Thoughts from CROI 2016 – Josephine Ayankoya
- CROI, For the First Time – Yvette Raphael
For further background information, press releases and other useful resources on the ring trial results, visit here.
Additional Coverage
As in years past, aidsmap covered the conference with their excellent in-depth reporting across a range of research areas, including HIV prevention. Their full coverage is available here.
Post-CROI webinar series
We will be convening a series of post-CROI webinars covering a range of topics over the next couple of months. For more information on upcoming webinars and for slides and audio from past webinars, click here.
And stay tuned to our Advocates’ Network emails to be the first to know about additional webinars in the series!
Webcasts and Posters
All CROI webcasts may be accessed here. Electronic posters will be available a week after the conference.
Tweets from #CROI2016
Avac Event
Exploring Dapivirine Ring Results
In the first webinar in our post-CROI webinar series, Jared Baeten (MTN) and Zeda Rosenberg (IPM) spoke about the dapivirine ring trial results announced at the conference and fielded questions from webinar participants.
Download slides and audio from the webinar. A video version is available below.
Avac Event
PrEP and Women in the US: Update on the science, research and implementation
The US women and PrEP Working Group held a webinar on the state of the science and implementation of PrEP for women in the US. Slides are available below.
Avac Event
Long-Acting Injectables Antiretrovirals for Treatment and Prevention
Heard about a “tail” for long-acting injectables and want to know more? Interested in the timeline for when people with HIV might have injectable drug options for treatment? Wondering how people felt about getting an injection for PrEP? David Margolis (ViiV Healthcare) and Marty Markowitz (Aaron Diamond AIDS Research Center) spoke about long-acting injectable antiretrovirals for treatment and prevention.
Click for the slides and an audio recording. A link to the Flash animation is below.
At CROI, Margolis presented findings from the LATTE 2 trial, which tested a pair of long-acting injectables—cabotegravir (from ViiV Healthcare) and rilpivarine (from Janssen)—for HIV maintenance therapy, and Markowitz presented findings from the ÉCLAIR paste 2A study of cabotegravir in HIV-uninfected men.
And this webinar is part of our post-2016 CROI webinar series. Click for more information.
Avac Event
Harnessing Antibodies for HIV Prevention and Treatment
John Mascola of the NIH Vaccine Research Center spoke about harnessing antibodies for HIV prevention and treatment. The recording includes a question and answer period with webinar participants.
For further background, click here to view his CROI plenary session. And this webinar is part of our post-CROI 2016 webinar series. Click to learn more.
Avac Event
New York State 2016 HIV Cure Symposium: Connecting Research to Clinical Practice
This full day symposium will focus on progress being made in HIV cure research. It will highlight (1) research to improve stem cell transplants; (2) gene editing technology; (3) advances in immune modulators and latency reversing agents; (4) ethical concerns related to treatment interruption and patient risk; and (5) policy barriers.
At the conclusion of the symposium, participants should be able to:
- Increase capacity of medical providers to discuss HIV cure research with patients
- Summarize barriers of conducting HIV cure research in NY State and identify strategies to remove those barriers
- Examine the place of HIV cure in the HIV care continuum
This symposium is restricted to New York State clinical providers, such as physicians, physician assistants, nurse practitioners, dentists, and pharmacists. Space will be limited!
Location:
New York University Kimmel Center
60 Washington Square South
New York, NY 10012
For More Information:
Contact Sainabou Jobe at [email protected] or 212-523-7284.
Avac Event
Community Perspectives from CROI 2016
Community Perspectives from CROI 2016 was the second in the 2016 WATCH webinar series that offers women living with HIV capacity building and training on HIV disease and treatment advocacy. During this webinar, participants received an overview of HIV science by several speakers, including:
- Treatment Advocacy, Kate Borloglou, Community Advisory Board, The Well Project, Community Scientific Subcommittee, AIDS Clinical Trials Group (ACTG)
- Pre-Exposure Prophylactics Research Updates from CROI 2016, Lisa Diane White, Deputy Director, SisterLove, Inc.
- Ring, Injectables & Cure Research Updates from CROI 2016, Jessica Salzdewel, Program Coordinator, AVAC
This webinar series was moderated by Krista Martel, Executive Director, The Well Project.
Avac Event
PrEP in the Wild — A whirlwind tour of the who, what, where and how of PrEP use and provision outside of approval
In this webinar, presenters spoke about PrEP’s use and provision in countries that haven’t yet approved it or who are in the early days post approval. Among others, these presenters from Thailand, South Africa, England, Peru, Mexico and the United States took on the following questions and more:
- Where is informal PrEP (“in the wild”) happening, among which populations?
- What are the perspectives of patients and providers?
- Are people following the full PrEP program (i.e. regular HIV and STI testing, medical monitoring, adherence support, sexual health counseling, other care)?
- What do advocacy efforts look like in different countries?
- What are the public’s perceptions of PrEP in different countries?
- How can the “PrEP in the Wild” global survey help your work?
Watch a Flash animation version of the webinar.